EXPRS2.ST
ExpreS2ion Biotech Holding AB
Price:  
29.60 
SEK
Volume:  
74,878.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXPRS2.ST WACC - Weighted Average Cost of Capital

The WACC of ExpreS2ion Biotech Holding AB (EXPRS2.ST) is 6.8%.

The Cost of Equity of ExpreS2ion Biotech Holding AB (EXPRS2.ST) is 5.95%.
The Cost of Debt of ExpreS2ion Biotech Holding AB (EXPRS2.ST) is 30.95%.

Range Selected
Cost of equity 5.00% - 6.90% 5.95%
Tax rate 8.20% - 8.80% 8.50%
Cost of debt 7.00% - 54.90% 30.95%
WACC 5.0% - 8.5% 6.8%
WACC

EXPRS2.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.48 0.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.00% 6.90%
Tax rate 8.20% 8.80%
Debt/Equity ratio 0.04 0.04
Cost of debt 7.00% 54.90%
After-tax WACC 5.0% 8.5%
Selected WACC 6.8%